임신 중 cannabidiol - derived from extract or tincture or resin of cannabis을 피해야 할까요? | VeriMom
There are multiple animal studies showing developmental and reproductive effects (rodent and zebrafish developmental toxicity, decreased pup survival and long-term behavioural/metabolic effects) and regulatory scrutiny by SCCS. CBD has been shown to affect developmental pathways in animals and is under active safety review for cosmetic use in the EU (SCCS preliminary opinion). Although a harmonised EU CLP Category 1 (H360) is not established, the weight of animal evidence and existing H361 self-notifications justify 'suspected' reproductive hazard (h=2) and a demonstrated mechanistic concern (m=2). Topical cosmetic exposure is generally low but measurable (e=1). (Sources: SCCS preliminary opinion; multiple peer‑reviewed developmental/reproductive animal studies; ECHA submissions/SDS noting H361.)
ECHA regulatory hazard statements
- •H361
What to use instead
Pregnancy-safe ingredients that serve a similar function:
FAQ
- cannabidiol - derived from extract or tincture or resin of cannabis은 임신 중 안전한가요?
- There are multiple animal studies showing developmental and reproductive effects (rodent and zebrafish developmental toxicity, decreased pup survival and long-term behavioural/metabolic effects) and regulatory scrutiny by SCCS. CBD has been shown to affect developmental pathways in animals and is under active safety review for cosmetic use in the EU (SCCS preliminary opinion). Although a harmonised EU CLP Category 1 (H360) is not established, the weight of animal evidence and existing H361 self-notifications justify 'suspected' reproductive hazard (h=2) and a demonstrated mechanistic concern (m=2). Topical cosmetic exposure is generally low but measurable (e=1). (Sources: SCCS preliminary opinion; multiple peer‑reviewed developmental/reproductive animal studies; ECHA submissions/SDS noting H361.)
- cannabidiol - derived from extract or tincture or resin of cannabis은 모유 수유 중 안전한가요?
- CBD has been detected in human breast milk and professional guidance (Pediatrics/FDA commentary) recommends caution because data on nursing women using CBD/Epidiolex are limited. Animal developmental effects plus documented milk transfer support suspected hazard (h=2) and demonstrated exposure pathway (m=2). For topical cosmetic use maternal systemic exposure is likely low but measurable, so infant exposure via milk is possible though expected to be low from topical use (e=1).
- cannabidiol - derived from extract or tincture or resin of cannabis은 아기 피부에 안전한가요?
- Infant skin has higher absorption per body weight; CBD shows biological activity in developmental models. Per scoring rules, increase exposure score by +1 for 0–3 y olds when adult absorption is measurable, giving e=2. Hazard remains 'suspected' based on animal developmental/reproductive data and regulatory concern (h=2) but infant-specific mechanistic data are limited (m=2 reflects demonstrated developmental/endocrine‑relevant activity in models).
- VeriMom은 cannabidiol - derived from extract or tincture or resin of cannabis을 어떻게 평가하나요?
- VeriMom은 EU CosIng, ECHA 분류, PubMed 연구를 기반으로 cannabidiol - derived from extract or tincture or resin of cannabis을 20/100 (높은 위험)로 평가합니다.
- 임신 중 cannabidiol - derived from extract or tincture or resin of cannabis 대체 안전 성분은?
- 유사한 기능을 가진 알려진 위험이 없는 대체 성분 목록을 확인하세요.
모든 성분표를 2초 만에 확인
VeriMom 무료 다운로드 — 어떤 제품이든 스캔해 임신 중 안전 점수를 즉시 확인하세요.
의료 면책 조항
이 정보는 교육 목적으로만 제공되며 의학적 조언을 구성하지 않습니다. 안전 점수는 공개적으로 이용 가능한 데이터를 기반으로 하며 모든 위험을 반영하지 않을 수 있습니다. 임신 중 또는 수유 중 제품을 사용하기 전에 항상 의료 전문가와 상담하십시오.